NCT02631928 - Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Diabetes Mellitus

Interventions

DRUG

human biphasic insulin

investigational insulin, biosimilar human insulin suspension of 30% normal insulin and 70% basal protamined insulin

DRUG

human biphasic insulin, reference

marketed product, human insulin suspension of 30% normal insulin and 70% basal (NPH) insulin

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss